P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors

Connelly Smith, Laura; Pattinson, Joanne; Grundy, Martin; Shang, Shili; Seedhouse, Claire; Russell, Nigel; Pallis, Monica

doi:10.1016/j.exphem.2007.07.017

All Outputs (2)

Low dose rapamycin does not modulate p-glycoprotein function in acute myeloid leukaemia (2007)
Journal Article
Shang, S., Seedhouse, C., Russell, N., & Pallis, M. (2008). Low dose rapamycin does not modulate p-glycoprotein function in acute myeloid leukaemia. Leukemia Research, 32(5), 836-837. https://doi.org/10.1016/j.leukres.2007.08.021

P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors (2007)
Journal Article
Connelly Smith, L., Pattinson, J., Grundy, M., Shang, S., Seedhouse, C., Russell, N., & Pallis, M. (2007). P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors. Experimental Hematology, 35(12), 1793-1800. https://doi.org/10.1016/j.exphem.2007.07.017

Objective P-glycoprotein (pgp) is a membrane transporter encoded by the multidrug resistance (MDR1, ABCB1) gene. Pgp is a poor prognostic factor in elderly patients with acute myeloid leukemia (AML). In addition to its role in drug efflux, pgp has b... Read More about P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors.